Natus Medical Buys Alpine Biomed To Expand Neurodiagnostics Portfolio
This article was originally published in The Gray Sheet
Executive Summary
Natus Medical will expand its global presence in the neurology market through its $43.2 million acquisition of neurological disorder diagnostic equipment maker Alpine Biomed, announced Sept. 14